Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

3.
4.
5.
6.
7.

Diallyl sulfide enhances azoxymethane-induced preneoplasia in Fischer 344 rat colon.

Delker DA, Papanikolaou A, Suhr YJ, Rosenberg DW.

Chem Biol Interact. 2000 Feb 1;124(3):149-60.

PMID:
10728775
8.

Suppressing effect of perilla oil on azoxymethane-induced foci of colonic aberrant crypts in rats.

Onogi N, Okuno M, Komaki C, Moriwaki H, Kawamori T, Tanaka T, Mori H, Muto Y.

Carcinogenesis. 1996 Jun;17(6):1291-6.

PMID:
8681445
9.

Chemoprevention of colonic aberrant crypt foci by an inducible nitric oxide synthase-selective inhibitor.

Rao CV, Kawamori T, Hamid R, Reddy BS.

Carcinogenesis. 1999 Apr;20(4):641-4.

PMID:
10223193
10.
11.

Efficacy of potential chemopreventive agents on rat colon aberrant crypt formation and progression.

Wargovich MJ, Jimenez A, McKee K, Steele VE, Velasco M, Woods J, Price R, Gray K, Kelloff GJ.

Carcinogenesis. 2000 Jun;21(6):1149-55.

PMID:
10837003
12.

Inhibitory effect of caffeic acid esters on azoxymethane-induced biochemical changes and aberrant crypt foci formation in rat colon.

Rao CV, Desai D, Simi B, Kulkarni N, Amin S, Reddy BS.

Cancer Res. 1993 Sep 15;53(18):4182-8.

13.

Ability of aberrant crypt foci characteristics to predict colonic tumor incidence in rats fed cholic acid.

Magnuson BA, Carr I, Bird RP.

Cancer Res. 1993 Oct 1;53(19):4499-504.

PMID:
8402621
14.

Inhibition of development of N,N'-dimethylhydrazine-induced rat colonic aberrant crypt foci by pre, post and simultaneous treatments with 24R,25-dihydroxyvitamin D3.

Salim EI, Wanibuchi H, Taniyama T, Yano Y, Morimura K, Yamamoto S, Otani S, Nishizawa Y, Morii H, Fukushima S.

Jpn J Cancer Res. 1997 Nov;88(11):1052-62.

PMID:
9439680
15.

Dietary fiber and the chemopreventive modelation of colon carcinogenesis.

Alabaster O, Tang Z, Shivapurkar N.

Mutat Res. 1996 Feb 19;350(1):185-97.

PMID:
8657180
16.

Senna and the formation of aberrant crypt foci and tumors in rats treated with azoxymethane.

Borrelli F, Capasso R, Aviello G, Di Carlo G, Izzo AA, Mascolo N, Capasso F.

Phytomedicine. 2005 Jun;12(6-7):501-5; discussion 505.

PMID:
16008128
17.

Suppression of azoxymethane-induced colonic aberrant crypt foci by a nitric oxide synthase inhibitor.

Kawamori T, Takahashi M, Watanabe K, Ohta T, Nakatsugi S, Sugimura T, Wakabayashi K.

Cancer Lett. 2000 Jan 1;148(1):33-7.

PMID:
10680590
18.

Suppression of azoxymethane-induced rat colon aberrant crypt foci by dietary protocatechuic acid.

Kawamori T, Tanaka T, Kojima T, Suzui M, Ohnishi M, Mori H.

Jpn J Cancer Res. 1994 Jul;85(7):686-91.

PMID:
8071110
19.

Synergistic effects of (-)-epigallocatechin gallate with sulindac against colon carcinogenesis of rats treated with azoxymethane.

Ohishi T, Kishimoto Y, Miura N, Shiota G, Kohri T, Hara Y, Hasegawa J, Isemura M.

Cancer Lett. 2002 Mar 8;177(1):49-56.

PMID:
11809530
20.

Inhibition of aberrant crypt foci by chemopreventive agents.

Olivo S, Wargovich MJ.

In Vivo. 1998 Mar-Apr;12(2):159-66. Review.

PMID:
9627797

Supplemental Content

Support Center